ObsEva SA to Attend BioEquity Europe 2017 in Paris
(Thomson Reuters ONE) -
ObsEva SA /
ObsEva SA to Attend BioEquity Europe 2017 in Paris
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Geneva, Switzerland - 16 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss
biopharmaceutical company focused on the development and commercialization of
novel therapeutics for serious conditions that compromise a woman's reproductive
health and pregnancy, today announced that Ben T.G. TAN, VP Commercial &
Business Development, will attend the BioEquity Europe 2017 Conference. Ben T.G.
TAN will be presenting on Monday May 22(nd) at 2:20 pm and will be hosting one-
on-one meetings at the Marriott Rive Gauche in Paris, France.
About ObsEva
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical
development and commercialization of novel therapeutics for serious conditions
that compromise a woman's reproductive health and pregnancy. Through strategic
in-licensing and disciplined drug development, ObsEva has established a late-
stage clinical pipeline with development programs focused on treating
endometriosis, uterine fibroids, preterm labor and improving ART outcomes.
ObsEva is listed on The NASDAQ Global Select Market and is trading under the
ticker symbol "OBSV". For more information, please visit www.ObsEva.com.
###
Media Contact:
Liz Bryan
Spectrum Science
lbryan(at)spectrumscience.com
202-955-6222 x2526
Company Contact:
Delphine Renaud
ObsEva, CEO Office
delphine.renaud(at)obseva.ch
+41 22 552 1550
Press Release:
http://hugin.info/157613/R/2104928/798873.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ObsEva SA via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 16.05.2017 - 13:00 Uhr
Sprache: Deutsch
News-ID 543786
Anzahl Zeichen: 2349
contact information:
Town:
Plan-les-Ouates
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 172 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ObsEva SA to Attend BioEquity Europe 2017 in Paris"
steht unter der journalistisch-redaktionellen Verantwortung von
ObsEva SA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
